Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature
about
Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markersNon-small cell lung cancer cells expressing CD44 are enriched for stem cell-like propertiesDistinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancersMUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cellsDouble-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cellsCD133: to be or not to be, is this the real question?c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsTumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancerThresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009Management of relapsed ovarian cancer: a reviewAnti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalThe IL-8/IL-8R Axis: A Double Agent in Tumor Immune ResistanceOncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancerRoles for miRNAs in endocrine resistance in breast cancerA review on hepatocyte nuclear factor-1beta and tumorAldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsSteroid hormones, steroid receptors, and breast cancer stem cellsTumor-Derived Cell Lines as Molecular Models of Cancer PharmacogenomicsIn vivo molecular imaging of cancer stem cellsTumor heterogeneity and its implication for drug deliveryEmerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachIdentifying and targeting tumor-initiating cells in the treatment of breast cancerPancreatic cancer stem cells: emerging target for designing novel therapyTargeting CSC-related miRNAs for cancer therapy by natural agentsMetastatic mechanisms in follicular cell-derived thyroid cancerGenomic profiling in triple-negative breast cancerWound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancerInflammatory breast cancer: New factors contribute to disease etiology: A reviewHigh efficiency integration of three-dimensional functional microdevices inside a microfluidic chip by using femtosecond laser multifoci parallel microfabricationThe Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancerTrastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitorsMammary gland stem cells and their application in breast cancerIn vitro models of cancer stem cells and clinical applicationsTargeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and TreatmentABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuitA perspective on cancer cell metastasisErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasisThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisDoxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models
P2860
Q21195203-9B7045F2-20DE-4EEF-B24C-E2BA4226F25BQ21562142-2D70C774-1DDB-4CE0-B945-4FBCF496C496Q21562662-68A566AF-60E3-4C97-813E-7A5090EF7E1AQ24336566-6C2DDC51-2BDF-4D49-A105-67E17C013C72Q24598592-FDA936C0-0A49-4ACF-AA41-789C3E0F1C42Q24615405-4CF183C1-A6CA-4899-BD43-63423DCA58C5Q24633165-9F366657-FEAB-42F6-BB4D-BA7FBEB180E4Q24642170-A7A19714-DD56-40E7-8DC7-B186C6B821A0Q24652733-BDB4193E-1CBA-424E-B045-C90041B4D0E3Q24657145-135D2C82-1681-4155-A7FF-1877D213BD18Q26741755-DD09AB84-3E85-455F-BD98-BA158AEE3296Q26744536-E257C6D7-F7BA-41FC-80E0-43857C6C4CCFQ26746986-4C7D6913-1922-461C-B687-6112BF12AC5CQ26750563-691755E9-A81D-4C4B-BB40-DF1D9FEDDFAFQ26783076-22068CD0-323A-4EC9-9DE5-AC2E350BE9D1Q26783312-C6205745-6925-4974-8C11-E136A9C92C3BQ26786476-40DEDE7E-55AE-4D40-A7A7-D65B5EAEF0A8Q26799113-ED6F1070-7B1C-424D-8547-B1507BDEA130Q26801410-466F2A6E-C9AA-4B73-B8B3-3E4A280B54B6Q26828630-BB27C604-360B-49B6-B6C0-8CE2E0741561Q26829096-91E20E3F-0BD1-4DF3-8EAC-E24345D5D252Q26849477-F53822E6-E4EE-4AB5-8F4E-F2203D3DCF68Q26851827-68C23339-6016-4500-A873-108B00354CFDQ26863365-52595DF1-EE8A-4A87-A707-4654348EBC97Q27003230-77407ABF-2C18-4D78-A159-ED0B0F1B04BBQ27005646-FA3113A7-8513-40B2-AC0D-F4FE21B20B13Q27015775-F351BB9B-8EB4-4715-8109-1175A6908A1AQ27023599-DBB11C72-93CB-4541-84A9-490ECACBA7CAQ27027856-D0457DB8-E76C-4C31-B50F-7BAA2531E2FAQ27300657-5B236DC4-BE77-426C-858B-6DB6E2F10EFCQ27315124-8D2B607F-B306-47A1-A84F-07B573D1F318Q27851975-877807D2-F06D-489D-9EFB-3FE700175B92Q28075791-9386FCE2-CFB8-431C-9129-23D2C5BA1636Q28076101-9EF354DA-A8E8-433C-83A6-D5B1CC3743E9Q28076462-6E4CB48A-D045-4AA0-9EE1-1CDD6A6E45F0Q28242049-70AF29E8-6D0F-4A42-BB7E-94DD2B459F28Q28307891-4E07F429-E739-4F1A-92EB-66E6A86D85B9Q28384120-1F710CC9-755E-4A33-96C2-422D5CB693A4Q28388257-6FC54601-2A59-4BF4-A951-B300B79E0075Q28473783-5A2DDBFA-EB7E-450B-87EA-D9174EC1C247
P2860
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Breast cancer cell lines conta ...... a distinct molecular signature
@ast
Breast cancer cell lines conta ...... a distinct molecular signature
@en
type
label
Breast cancer cell lines conta ...... a distinct molecular signature
@ast
Breast cancer cell lines conta ...... a distinct molecular signature
@en
prefLabel
Breast cancer cell lines conta ...... a distinct molecular signature
@ast
Breast cancer cell lines conta ...... a distinct molecular signature
@en
P2093
P2860
P50
P3181
P1433
P1476
Breast cancer cell lines conta ...... a distinct molecular signature
@en
P2093
Florence Monville
François Bertucci
Gabriela Dontu
Giorgio Stassi
Julie Dutcher
Julien Wicinski
Mark E Diebel
Marty Brown
Max S Wicha
P2860
P304
P3181
P356
10.1158/0008-5472.CAN-08-2741
P407
P577
2009-02-03T00:00:00Z